Literature DB >> 2313564

Obstacles to the optimal management of HIV infection/AIDS in Africa.

B N'Galy1, S Bertozzi, R W Ryder.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2313564

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


× No keyword cloud information.
  4 in total

1.  AIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach.

Authors:  Peter M Mwamba; Walter O Mwanda; Naftaliw Busakhala; R Matthew Strother; Patrick J Loehrer; Scot C Remick
Journal:  Lymphoma       Date:  2012

2.  Utility of quantitative enzyme immunoassay reactivity for predicting human immunodeficiency virus seropositivity in low- and high-prevalence populations.

Authors:  X Hou; P L Breese; J M Douglas
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

3.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.

Authors:  Walter O Mwanda; Jackson Orem; Pingfu Fu; Cecilia Banura; Joweria Kakembo; Caren Auma Onyango; Anne Ness; Sherrie Reynolds; John L Johnson; Vivek Subbiah; Jacob Bako; Henry Wabinga; Fatuma K Abdallah; Howard J Meyerson; Christopher C Whalen; Michael M Lederman; Jodi Black; Leona W Ayers; Edward Katongole-Mbidde; Scot C Remick
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.